Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Octenidine is a cationic surfactant and antiseptic agent used primarily for topical disinfection of skin, mucous membranes, wounds, and in oral care. It exhibits broad-spectrum antimicrobial activity against Gram-positive and Gram-negative bacteria as well as fungi. Its mechanism of action involves binding to phospholipids and lipopolysaccharides in microbial cell membranes, leading to membrane disruption and cell death[1][2][5]. Octenidine is not systemically absorbed when applied topically or on mucosa[5]. It has been widely used in Europe since the late 1980s as an alternative to chlorhexidine due to its efficacy and low toxicity profile[7]. Clinical uses include preoperative skin preparation, wound antisepsis, oral rinses for periodontitis/gingivitis prevention, Staphylococcus aureus decolonization (including MRSA), catheter site care, and prevention of nosocomial infections such as surgical site infections[6][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on octenidine.